9-133777449-T-G
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_001134398.2(VAV2):āc.1905A>Cā(p.Gln635His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000595 in 1,613,546 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001134398.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
VAV2 | NM_001134398.2 | c.1905A>C | p.Gln635His | missense_variant | 23/30 | ENST00000371850.8 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
VAV2 | ENST00000371850.8 | c.1905A>C | p.Gln635His | missense_variant | 23/30 | 1 | NM_001134398.2 | A1 | |
VAV2 | ENST00000406606.7 | c.1875A>C | p.Gln625His | missense_variant | 21/27 | 1 | P4 | ||
VAV2 | ENST00000371851.1 | c.1875A>C | p.Gln625His | missense_variant | 21/28 | 5 | A1 |
Frequencies
GnomAD3 genomes AF: 0.000361 AC: 55AN: 152162Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000557 AC: 14AN: 251334Hom.: 0 AF XY: 0.0000294 AC XY: 4AN XY: 135860
GnomAD4 exome AF: 0.0000281 AC: 41AN: 1461384Hom.: 0 Cov.: 30 AF XY: 0.0000179 AC XY: 13AN XY: 726984
GnomAD4 genome AF: 0.000361 AC: 55AN: 152162Hom.: 0 Cov.: 32 AF XY: 0.000444 AC XY: 33AN XY: 74334
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 21, 2024 | The c.1905A>C (p.Q635H) alteration is located in exon 23 (coding exon 23) of the VAV2 gene. This alteration results from a A to C substitution at nucleotide position 1905, causing the glutamine (Q) at amino acid position 635 to be replaced by a histidine (H). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at